Workflow
Bitfarms .(BITF) - 2025 Q4 - Earnings Call Transcript
2026-03-31 13:02
Bitfarms (NasdaqGM:BITF) Q4 2025 Earnings call March 31, 2026 08:00 AM ET Company ParticipantsBen Gagnon - CEO and DirectorBrett Knoblauch - Head of Digital Asset ResearchBrian Kinstlinger - Director of Research, Managing Director, and Head of Technology ResearchJennifer Drew-Bear - Senior AssociateJonathan Mir - CFOMartin Toner - Managing Director of Institutional Equity ResearchMichael Donovan - Senior Research ResearchMike Colonnese - Managing Director of Equity ResearchMike Grondahl - Head of Equities a ...
DiaMedica Therapeutics(DMAC) - 2025 Q4 - Earnings Call Transcript
2026-03-31 13:02
DiaMedica Therapeutics (NasdaqCM:DMAC) Q4 2025 Earnings call March 31, 2026 08:00 AM ET Company ParticipantsJosh Schimmer - Managing DirectorJulie Krop - Chief Medical OfficerMatthew Caufield - VP of Equity ResearchRick Pauls - CEO and PresidentScott Kellen - CFOStacy Ku - Biotechnology Equity ResearchConference Call ParticipantsChase Knickerbocker - Senior Research AnalystThomas Flaten - Senior Research AnalystOperatorMorning, ladies and gentlemen, and welcome to the DiaMedica Therapeutics full year 2025 e ...
Chagee(CHA) - 2025 Q4 - Earnings Call Transcript
2026-03-31 13:02
Chagee (NasdaqGS:CHA) Q4 2025 Earnings call March 31, 2026 08:00 AM ET Company ParticipantsAaron Huang - CFOAlicia Guo - Investor Relations DirectorDengfeng Yin - Director and Chief Operating OfficeJunjie Zhang - Chairman and CEOConference Call ParticipantsJessie Xu - AnalystLillian Lou - AnalystSijie Lin - AnalystXiaopo Wei - AnalystOperatorGood morning and good evening, ladies and gentlemen. Thank you for standing by and welcome to Chagee's fourth quarter 2025 earnings conference call. At this time, all p ...
DiaMedica Therapeutics(DMAC) - 2025 Q4 - Earnings Call Transcript
2026-03-31 13:02
DiaMedica Therapeutics (NasdaqCM:DMAC) Q4 2025 Earnings call March 31, 2026 08:00 AM ET Company ParticipantsDietrich John Pauls - President and CEOJosh Schimmer - Managing DirectorJulie Krop - Chief Medical OfficerMatthew Caufield - VP of Equity ResearchMitchel Morgan - Manager of Clinical SuppliesScott Kellen - CFOStacy Ku - Biotechnology Equity ResearchConference Call ParticipantsChase Knickerbocker - Senior Research AnalystThomas Flaten - Senior Research AnalystOperatorMorning, ladies and gentlemen, and ...
Palisade Bio (NasdaqCM:PALI) Update / briefing Transcript
2026-03-31 13:02
Palisade Bio (NasdaqCM:PALI) Update / briefing March 31, 2026 08:00 AM ET Company ParticipantsAlex Thompson - Managing DirectorFlorian Rieder - Clinical Advisory Board MemberJD Finley - CEOMitchell Jones - President and Chief Medical OfficerWayne Wu - Senior AssociateConference Call ParticipantsAydin Huseynov - Equity Research AnalystKatie Degen - Associate Biotech Research AnalystNaz Rahman - AnalystWilliam Wood - Biotech Equity Research AnalystYasmeen Rahimi - Managing Director and Senior Research Analyst ...
Jiayin Group(JFIN) - 2025 Q4 - Earnings Call Transcript
2026-03-31 13:00
Jiayin Group (NasdaqGM:JFIN) Q4 2025 Earnings call March 31, 2026 08:00 AM ET Speaker2Good day, ladies and gentlemen. Thank you for standing by, and welcome to the Jiayin Group's fourth quarter 2025 earnings conference call. Currently, all participants are in listen-only mode. Later, we will conduct a question and answer session, and instructions will follow at that time. As a reminder, we are recording today's call. If you have any objections, you may disconnect at this time. I will now turn the call over ...
Constellation Energy (NasdaqGS:CEG) Update / briefing Transcript
2026-03-31 13:02
Constellation Energy (NasdaqGS:CEG) Update / briefing March 31, 2026 08:00 AM ET Company ParticipantsDavid Arcaro - Executive Director, Equity ResearchJames West - Managing Director and Head of Energy and Power ResearchJoe Dominguez - President and CEOJulien Dumoulin-Smith - Managing Director of U.S. Power, Utilities, and Clean Energy Equity ResearchShane Smith - EVP and CFOTim Flottemesch - VP of Investor RelationsConference Call ParticipantsAngie Storozynski - Managing Director and Senior Equity Research ...
Golden Matrix (GMGI) - 2025 Q4 - Earnings Call Transcript
2026-03-31 13:00
Meridian Holdings (NasdaqCM:GMGI) Q4 2025 Earnings call March 31, 2026 08:00 AM ET Speaker0Good morning, everyone, and welcome to Meridian Holdings fourth quarter and full year 2025 earnings call. With us on today's call are William Scott, Interim Chief Executive Officer of Meridian Holdings, Rich Christensen, Chief Financial Officer of Meridian Holdings, and Zoran Milosevic, Chief Executive Officer of Meridianbet Group, a subsidiary of Meridian Holdings. At the conclusion of the call, a recording and other ...
Repay (NasdaqCM:RPAY) M&A announcement Transcript
2026-03-31 13:02
Repay (NasdaqCM:RPAY) M&A announcement March 31, 2026 08:00 AM ET Company ParticipantsJohn Morris - Co-founder and CEORobert Houser - CFOStewart Grisante - Head of Investor RelationsTimothy Chiodo - Director of Equity ResearchConference Call ParticipantsCharles Nabhan - Managing Director and Equity Research AnalystJoseph Vafi - Managing Director and Senior Equity Research AnalystPeter Heckmann - Managing Director and Senior Research AnalystOperatorGreetings. Welcome to Repay Holdings Corporation's Acquisiti ...
FREYR(FREY) - 2025 Q4 - Earnings Call Transcript
2026-03-31 13:00
T1 Energy (NYSE:FREY) Q4 2025 Earnings call March 31, 2026 08:00 AM ET Speaker6Good day, and thank you for standing by. Welcome to the T1 Energy Fourth Quarter Earnings Conference Call. At this time, all participants are in listen only mode. After the speaker's presentation, there'll be a question and answer session. To ask a question during the session, you'll need to press star one one on your telephone. You will then hear an automated message advising your hand is raised. To withdraw your question, pleas ...